• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱泼斯坦-巴尔病毒/C3dg受体(CR2)的流体动力学、电子显微镜及配体结合分析

Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2).

作者信息

Moore M D, DiScipio R G, Cooper N R, Nemerow G R

机构信息

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

出版信息

J Biol Chem. 1989 Dec 5;264(34):20576-82.

PMID:2555366
Abstract

The interaction of the Epstein-Barr virus/45-kDa proteolytic fragment of C3 (C3dg) receptor (CR2) with its viral ligand, the Epstein-Barr virus glycoprotein gp350/220, initiates the sequence of events leading to virus internalization and B lymphocyte transformation. Soluble recombinant receptor (rCR2) and gp350/220 as well as the natural ligand, C3dg, were subjected to a number of analytical techniques including gel permeation chromatography, density gradient ultracentrifugation, circular dichroism, and electron microscopy in order to determine their hydrodynamic, structural, and binding properties. Both rCR2 and gp350/220 were found to be highly extended proteins (f/fo = 2.1 and 2.4/2.2, respectively). C3dg, in contrast to the viral ligand, is only somewhat elongated (f/fo = 1.5). Soluble rCR2, visualized by high resolution electron microscopy, was shown to be an extended, highly flexible molecule comprised of ringlet domains, each approximately 24.1 A in length, which likely correspond to the short consensus repeat motif deduced from the CR2 cDNA nucleotide sequence. Ligand-binding studies carried out under physiological conditions indicated that gp350/220 binding to rCR2 was saturable and univalent, with a dissociation constant of 3.2 nM. In contrast, monomeric C3dg did not bind to rCR2 under physiological conditions; however, at reduced ionic strength, monomeric C3dg binding could be measured. These studies indicate that the affinity of the C3dg monomer for rCR2 under physiologic conditions is approximately 10(4)-fold less than that of the viral ligand. The molecular properties of rCR2 revealed in these studies provide essential information for future studies of the biologic functions of the Epstein-Barr virus/C3dg receptor.

摘要

爱泼斯坦-巴尔病毒/补体C3 45-kDa蛋白水解片段(C3dg)受体(CR2)与其病毒配体——爱泼斯坦-巴尔病毒糖蛋白gp350/220之间的相互作用,引发了一系列导致病毒内化和B淋巴细胞转化的事件。可溶性重组受体(rCR2)、gp350/220以及天然配体C3dg接受了多种分析技术检测,包括凝胶渗透色谱法、密度梯度超速离心法、圆二色性分析和电子显微镜检查,以确定它们的流体动力学、结构和结合特性。结果发现,rCR2和gp350/220均为高度伸展的蛋白质(f/fo分别为2.1和2.4/2.2)。相比之下,病毒配体C3dg只是略有拉长(f/fo = 1.5)。通过高分辨率电子显微镜观察到,可溶性rCR2是一个由小环结构域组成的伸展且高度灵活的分子,每个小环结构域长度约为24.1 Å,这可能与从CR2 cDNA核苷酸序列推导得出的短共有重复基序相对应。在生理条件下进行的配体结合研究表明,gp350/220与rCR2的结合具有饱和性和单价性,解离常数为3.2 nM。相反,在生理条件下,单体C3dg不与rCR2结合;然而,在离子强度降低时,可以检测到单体C3dg的结合。这些研究表明,在生理条件下,C3dg单体对rCR2的亲和力比病毒配体低约10^4倍。这些研究中揭示的rCR2的分子特性为未来研究爱泼斯坦-巴尔病毒/C3dg受体的生物学功能提供了重要信息。

相似文献

1
Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2).爱泼斯坦-巴尔病毒/C3dg受体(CR2)的流体动力学、电子显微镜及配体结合分析
J Biol Chem. 1989 Dec 5;264(34):20576-82.
2
Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.C3d,g/爱泼斯坦-巴尔病毒受体(CR2/CD21)配体结合、内化及病毒感染的结构要求。
J Biol Chem. 1990 Jul 25;265(21):12293-9.
3
Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2.确定爱泼斯坦-巴尔病毒与人2型补体受体选择性结合的结构基础。
J Exp Med. 1991 Dec 1;174(6):1299-311. doi: 10.1084/jem.174.6.1299.
4
Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.补体受体2(CR2/CD21)重组N端短共有/补体重复结构域对在溶液中的结构研究及其与配体C3dg的相互作用
Biochemistry. 2001 May 22;40(20):5931-41. doi: 10.1021/bi0101749.
5
Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.将爱泼斯坦-巴尔病毒和C3dg结合位点定位到2型补体受体上的一个共同结构域。
J Exp Med. 1989 Dec 1;170(6):1931-46. doi: 10.1084/jem.170.6.1931.
6
Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats.含两个短共有重复序列的可溶性CR2(CD21)在体外和体内对爱泼斯坦-巴尔病毒感染的抑制作用
J Virol. 1991 Jul;65(7):3559-65. doi: 10.1128/JVI.65.7.3559-3565.1991.
7
CR2 complement receptor.CR2补体受体。
J Invest Dermatol. 1990 Jun;94(6 Suppl):112S-117S. doi: 10.1111/1523-1747.ep12876069.
8
Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.鉴定gp350作为介导爱泼斯坦-巴尔病毒(EBV)与B细胞的EBV/C3d受体结合的病毒糖蛋白:gp350与C3补体片段C3d的序列同源性。
J Virol. 1987 May;61(5):1416-20. doi: 10.1128/JVI.61.5.1416-1420.1987.
9
Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis.爱泼斯坦-巴尔病毒gp350/220与B淋巴细胞C3d受体的结合介导吸附、成帽作用和内吞作用。
Cell. 1987 Jul 17;50(2):203-13. doi: 10.1016/0092-8674(87)90216-9.
10
Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21).分离爱泼斯坦-巴尔病毒gp350/220在2型补体受体(CR2/CD21)上的结合位点。
J Biol Chem. 2007 Dec 14;282(50):36614-25. doi: 10.1074/jbc.M706324200. Epub 2007 Oct 9.

引用本文的文献

1
Cytokine Storm Syndromes Associated with Epstein-Barr Virus.细胞因子风暴综合征与 EBV 相关。
Adv Exp Med Biol. 2024;1448:227-248. doi: 10.1007/978-3-031-59815-9_16.
2
Structural biology of complement receptors.补体受体的结构生物学。
Front Immunol. 2023 Sep 11;14:1239146. doi: 10.3389/fimmu.2023.1239146. eCollection 2023.
3
The BDLF3 gene product of Epstein-Barr virus, gp150, mediates non-productive binding to heparan sulfate on epithelial cells and only the binding domain of CD21 is required for infection.
爱泼斯坦-巴尔病毒的BDLF3基因产物gp150介导与上皮细胞硫酸乙酰肝素的非生产性结合,并且感染仅需要CD21的结合结构域。
Virology. 2016 Jul;494:23-8. doi: 10.1016/j.virol.2016.04.002. Epub 2016 Apr 8.
4
EBV glycoproteins: where are we now?爱泼斯坦-巴尔病毒糖蛋白:我们目前进展到哪一步了?
Future Virol. 2015;10(10):1155-1162. doi: 10.2217/fvl.15.80.
5
Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pair.生物物理研究表明,补体受体 2(CD21 和 CR2)-配体相互作用揭示了每个受体-配体对的独特氨基酸接触。
J Biol Chem. 2010 Aug 27;285(35):27251-27258. doi: 10.1074/jbc.M110.106617. Epub 2010 Jun 17.
6
Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation.B族链球菌上一种新型表面蛋白获取H因子可促进补体降解。
FASEB J. 2009 Nov;23(11):3967-77. doi: 10.1096/fj.09-138149. Epub 2009 Jul 16.
7
The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.在非典型溶血性尿毒症综合征中,补体因子H与细胞上的生理性多阴离子和C3b复合物的结合受损。
J Immunol. 2009 Jun 1;182(11):7009-18. doi: 10.4049/jimmunol.0804031.
8
Polyanion-induced self-association of complement factor H.多聚阴离子诱导的补体因子H自缔合
J Immunol. 2009 Jan 15;182(2):1061-8. doi: 10.4049/jimmunol.182.2.1061.
9
Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2.人、绵羊和小鼠补体受体2型的分子结构与表达
Clin Vaccine Immunol. 2008 Jun;15(6):901-10. doi: 10.1128/CVI.00465-07. Epub 2008 Apr 9.
10
The murid herpesvirus-4 gH/gL binds to glycosaminoglycans.鼠疱疹病毒4型糖蛋白gH/gL与糖胺聚糖结合。
PLoS One. 2008 Feb 27;3(2):e1669. doi: 10.1371/journal.pone.0001669.